Impiricus ranks No. 14 on 2026 Inc. 5000 list

Impiricus landed at No. 14 on the 2026 Inc. 5000 after posting 11,691% three-year revenue growth from 2022 to 2025. The ranking spotlights the Atlanta healthcare AI company’s rapid rise as it pushes agentic AI tools aimed at speeding physician support and patient access to treatment.

Why it matters: - Impiricus’ No. 14 ranking puts the Atlanta company near the top of the 2026 Inc. 5000, a widely watched list of fast-growing private U.S. companies. - The ranking underscores how quickly healthcare commercialization tools built around AI are gaining traction. - Impiricus says the growth reflects demand from physicians and life sciences companies for faster, more relevant clinical support.

What happened: - Impiricus announced it ranked No. 14 on the 2026 Inc. 5000 list on Aug. 11, 2026. - The company posted 11,691% three-year revenue growth. - Inc. ranks companies by percentage revenue growth from 2022 to 2025. - The list recognizes privately held, for-profit, independent U.S. companies. - The full list and company profiles are available in Inc.'s searchable database.

The details: - Impiricus describes itself as building agentic AI infrastructure for healthcare commercialization. - The platform is designed to move physician engagement from information delivery to real-time clinical action. - The technology helps life sciences companies detect physician needs and connect health care professionals with relevant clinical resources, patient support and field teams. - Impiricus says its programs reach white-space, digitally dark and historically underserved physicians. - The company says that work is helping accelerate patient access to treatment across the U.S. - CEO and co-founder Dr. Osama Hashmi said the growth validates the problem Impiricus set out to solve and reflects trust from physicians, life sciences leaders and the company’s team. - Hashmi also said Impiricus is building agentic AI that turns physician engagement into real-time action and helps patients access treatment faster. - Inc. editor-in-chief Mike Hofman said honorees show perseverance, smart decision making and customer focus. - Inc. said the 2026 list includes companies across AI, advanced manufacturing, healthcare, consumer products and professional services. - The median three-year revenue growth rate among the 5,000 companies was 130%. - The honorees collectively added more than 627,208 jobs to the U.S. economy over the past three years.

Between the lines: - Impiricus is positioning itself as more than a messaging platform. - The company’s pitch centers on using AI to trigger action at the point of need, which could matter to drugmakers trying to improve physician reach and patient uptake. - The No. 14 placement gives Impiricus outside validation as it competes in a crowded healthcare technology market. - The Inc. ranking also signals that investors and customers are likely to keep watching whether rapid revenue growth translates into durable operational scale.

What's next: - Impiricus says it will keep building agentic AI tools that turn physician engagement into real-time action. - The company plans to expand the foundation it has built with physicians and life sciences customers. - Inc. will continue using its annual ranking to track private-company growth and publish honoree profiles for 2026.

The bottom line: - Impiricus is using a standout Inc. 5000 ranking to reinforce its claim that AI-driven physician engagement can speed treatment access and reshape healthcare commercialization.